Mauro M Teixeira Selected Research

2'- ((4'- trifluoromethanesulfonyloxy)phenyl)- N- methanesulfonylpropionamide

12/2018	Interleukin-33 contributes to disease severity in Dengue virus infection in mice.
1/2018	CXCR2 is critical for bacterial control and development of joint damage and pain in Staphylococcus aureus-induced septic arthritis in mouse.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mauro M Teixeira Research Topics

Disease

97	Inflammation (Inflammations) 01/2022 - 05/2002
67	Infections 03/2022 - 06/2002
22	Chagas Disease (American Trypanosomiasis) 10/2016 - 01/2002
18	Arthritis (Polyarthritis) 01/2022 - 06/2005
15	Reperfusion Injury 12/2007 - 05/2002
13	Gout 01/2022 - 02/2012
12	Pneumonia (Pneumonitis) 01/2022 - 02/2009
12	Ischemia 12/2007 - 04/2002
10	Wounds and Injuries (Trauma) 01/2019 - 01/2002
9	Neoplasms (Cancer) 01/2022 - 01/2004
9	Necrosis 10/2021 - 04/2002
9	Lung Injury 01/2020 - 03/2002
9	Fibrosis (Cirrhosis) 12/2018 - 04/2009
9	Asthma (Bronchial Asthma) 12/2018 - 10/2008
8	Pain (Aches) 01/2022 - 03/2010
8	Edema (Dropsy) 12/2020 - 09/2004
8	Hemorrhage 08/2009 - 06/2003
7	Dengue (Dengue Fever) 01/2019 - 12/2010
7	Sepsis (Septicemia) 01/2018 - 05/2002
6	Human Influenza (Influenza) 01/2021 - 11/2010
6	Virus Diseases (Viral Diseases) 01/2021 - 08/2014
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 03/2010
6	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2018 - 04/2009
6	Hyperalgesia 08/2017 - 07/2014
6	Parasitemia 10/2016 - 06/2004
6	Cardiomyopathies (Cardiomyopathy) 11/2012 - 11/2002
5	Pleurisy (Pleuritis) 01/2019 - 03/2002
4	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2016
4	Rheumatoid Arthritis 01/2022 - 09/2010
4	Zika Virus Infection 01/2021 - 01/2017
4	Thrombocytopenia (Thrombopenia) 05/2020 - 08/2009
4	Hypersensitivity (Allergy) 01/2018 - 11/2008
4	Colitis 03/2016 - 12/2009
4	Experimental Arthritis 01/2016 - 08/2010
4	Shock 01/2013 - 05/2002
4	Schistosomiasis mansoni 04/2011 - 12/2002
4	Granuloma 04/2011 - 12/2002
4	Heart Failure 08/2006 - 01/2004
3	Mucositis 01/2022 - 07/2014
3	Osteoarthritis 12/2020 - 12/2016
3	Microcephaly 10/2019 - 01/2017
3	Weight Loss (Weight Reduction) 01/2019 - 12/2009
3	Insulin Resistance 12/2018 - 09/2013

Drug/Important Bio-Agent (IBA)

54	CytokinesIBA 01/2022 - 04/2004
41	ChemokinesIBA 01/2020 - 05/2002
31	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2019 - 04/2002
23	AntigensIBA 01/2021 - 11/2003
18	Interleukin-10 (Interleukin 10)IBA 01/2018 - 04/2002
12	Chemokine ReceptorsIBA 01/2022 - 01/2004
12	Uric Acid (Urate)IBA 01/2022 - 06/2015
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2004
10	platelet activating factor receptorIBA 03/2014 - 03/2002
8	Peptides (Polypeptides)IBA 10/2021 - 11/2002
8	LigandsIBA 01/2019 - 12/2010
8	Platelet Activating FactorIBA 01/2012 - 03/2002
7	Antiviral Agents (Antivirals)IBA 03/2022 - 08/2014
7	Annexin A1IBA 01/2021 - 08/2012
6	GlucocorticoidsIBA 01/2022 - 08/2012
6	LipidsIBA 01/2021 - 07/2003
6	Interleukin-33IBA 12/2020 - 10/2008
6	Pharmaceutical PreparationsIBA 01/2019 - 01/2011
6	Bleomycin (Blenoxane)FDA LinkGeneric 12/2018 - 04/2009
6	InflammasomesIBA 06/2018 - 02/2012
5	VaccinesIBA 03/2022 - 10/2006
5	Acetates (Acetic Acid Esters)FDA Link 01/2020 - 04/2015
5	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019 - 07/2006
5	Phosphotransferases (Kinase)IBA 01/2019 - 05/2005
5	InterferonsIBA 01/2018 - 04/2006
5	OvalbuminIBA 05/2011 - 05/2003
5	Endothelins (Endothelin)IBA 03/2010 - 01/2002
5	Interleukin-4 (Interleukin 4)IBA 01/2009 - 04/2006
5	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2006 - 07/2003
4	Interleukin-17 (Interleukin 17)IBA 01/2022 - 05/2011
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 04/2002
4	CXC ChemokinesIBA 10/2021 - 09/2007
4	Messenger RNA (mRNA)IBA 01/2020 - 09/2013
4	Interleukin-8B ReceptorsIBA 12/2018 - 09/2004
4	CC ChemokinesIBA 01/2018 - 02/2009
4	Biomarkers (Surrogate Marker)IBA 01/2017 - 08/2007
4	CaspasesIBA 01/2017 - 05/2010
4	RolipramIBA 01/2017 - 08/2009
4	LipopolysaccharidesIBA 01/2017 - 05/2002
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2016 - 04/2006
4	Peroxidase (Myeloperoxidase)IBA 01/2016 - 01/2004
4	NitratesIBA 01/2012 - 04/2006
4	Interleukin-13IBA 05/2011 - 09/2006
4	CollagenIBA 04/2011 - 04/2005
4	EnzymesIBA 11/2010 - 05/2005
3	Complement System Proteins (Complement)IBA 03/2022 - 08/2005
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 07/2014
3	Interleukin-22 (IL-22)IBA 01/2022 - 05/2011
3	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2021 - 11/2012
3	Volatile Fatty AcidsIBA 01/2021 - 01/2017
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2017
3	Superoxides (Superoxide)IBA 12/2020 - 01/2012
3	PlasminogenIBA 01/2019 - 10/2014
3	Glucose (Dextrose)FDA LinkGeneric 12/2018 - 03/2014

Therapy/Procedure

17	Therapeutics 01/2022 - 01/2004
5	Ligation 03/2015 - 05/2002
4	Punctures 03/2015 - 05/2002